Skip to content
Recall Observatory FDA recall evidence

Drug product

Lansoprazole Delayed-Release Capsules USP, 15 mg, 14-count bottle, Manufactured by: Natco Pharma Limited Kothur- 509 228, India, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ. 08816. NDC 16571-742-41

D-0318-2024

February 01, 2024

Class II

Product summary

Firm
NATCO Pharma Limited
Event
Event 93868
Status
Terminated
Classification
Class II
Quantity
4260 bottles
Official record key
drug-enforcement:D-0318-2024

Official wording

Reason: CGMP Deviations: Inadequate induction sealing on bottles, capsules were observed with bubbles on band seal, capsules with holes and spheres sticking to capsules. Also coding details were missing on one bottle.

Code information: Lot # 411987 Exp: 05/2025

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations